• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高比例结直肠癌浸润的 LAP⁺Foxp3⁻T 细胞比 Foxp3⁺调节性 T 细胞表现出更强的免疫抑制活性。

Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells.

机构信息

Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.

Department of Pathology, University Hospital of Wales, Cardiff, UK.

出版信息

Mucosal Immunol. 2014 Mar;7(2):428-39. doi: 10.1038/mi.2013.62. Epub 2013 Sep 25.

DOI:10.1038/mi.2013.62
PMID:24064667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3931584/
Abstract

Although elevated CD4⁺Foxp3⁺ regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4⁺Foxp3⁺ and CD4⁺Foxp3⁻ T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation. Flow cytometry revealed that the majority of intratumoral CD4⁺Foxp3⁺ T cells (Tregs) were Helios⁺ and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood. Moreover, ∼30% of intratumoral CD4⁺Foxp3⁻ T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25. This unique population of cells produced interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), and was ∼50-fold more suppressive than Foxp3⁺ Tregs. Thus, intratumoral Tregs are diverse, posing multiple obstacles to immunotherapeutic intervention in colorectal malignancies.

摘要

尽管肿瘤内 CD4⁺Foxp3⁺调节性 T 细胞(Treg)频率升高已有充分记录,但来自匹配的血液、健康结肠和结直肠癌的 CD4⁺Foxp3⁺和 CD4⁺Foxp3⁻T 细胞亚群的功能和表型特征仍需要深入研究。流式细胞术显示,大多数肿瘤内 CD4⁺Foxp3⁺T 细胞(Tregs)为 Helios⁺,并且表达更高水平的细胞毒性 T 淋巴细胞抗原 4(CTLA-4)和 CD39,高于结肠和血液中的 Tregs。此外,约 30%的肿瘤内 CD4⁺Foxp3⁻T 细胞表达与调节功能相关的标志物,包括潜伏期相关肽(LAP)、淋巴细胞激活基因-3(LAG-3)和 CD25。该独特的细胞群产生白细胞介素-10(IL-10)和转化生长因子-β(TGF-β),其抑制作用比 Foxp3⁺Treg 强约 50 倍。因此,肿瘤内 Tregs 具有多样性,这对结直肠恶性肿瘤的免疫治疗干预构成了多重障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/9360e836dcf6/mi201362f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/c23bbccf9b0f/mi201362f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/1eea31751106/mi201362f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/29ae7fbdfb22/mi201362f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/76a5cafbce1e/mi201362f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/bcba4d438bef/mi201362f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/9360e836dcf6/mi201362f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/c23bbccf9b0f/mi201362f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/1eea31751106/mi201362f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/29ae7fbdfb22/mi201362f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/76a5cafbce1e/mi201362f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/bcba4d438bef/mi201362f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5d0/3932520/9360e836dcf6/mi201362f6.jpg

相似文献

1
Highly prevalent colorectal cancer-infiltrating LAP⁺ Foxp3⁻ T cells exhibit more potent immunosuppressive activity than Foxp3⁺ regulatory T cells.高比例结直肠癌浸润的 LAP⁺Foxp3⁻T 细胞比 Foxp3⁺调节性 T 细胞表现出更强的免疫抑制活性。
Mucosal Immunol. 2014 Mar;7(2):428-39. doi: 10.1038/mi.2013.62. Epub 2013 Sep 25.
2
Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.将FoxP3和Helios与GARP/LAP标志物相结合,能够识别癌症患者中扩增的调节性T细胞亚群。
Oncotarget. 2016 Mar 22;7(12):14083-94. doi: 10.18632/oncotarget.7334.
3
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.在结直肠癌组织中鉴定CD8+CD25+Foxp3+抑制性T细胞。
Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.
4
Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.两种 FOXP3(+)CD4(+) T 细胞亚群可明显控制结直肠癌的预后。
Nat Med. 2016 Jun;22(6):679-84. doi: 10.1038/nm.4086. Epub 2016 Apr 25.
5
Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.癌症患者中 CD4+ CD39+ FOXP3+ 和 CD4+ CD39+ FOXP3neg T 细胞亚群的表型和功能特征。
Eur J Immunol. 2012 Jul;42(7):1876-85. doi: 10.1002/eji.201142347. Epub 2012 Jun 18.
6
Determination of a CD4CD25FoxP3 T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-γ.结直肠癌引流淋巴结中分泌白细胞介素-2和干扰素-γ的CD4CD25FoxP3 T细胞亚群的测定。
Tumour Biol. 2016 Nov;37(11):14659-14666. doi: 10.1007/s13277-016-5345-y. Epub 2016 Sep 13.
7
Immune Checkpoints in Circulating and Tumor-Infiltrating CD4 T Cell Subsets in Colorectal Cancer Patients.结直肠癌患者循环和肿瘤浸润 CD4 T 细胞亚群中的免疫检查点。
Front Immunol. 2019 Dec 17;10:2936. doi: 10.3389/fimmu.2019.02936. eCollection 2019.
8
ICOS Foxp3 TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.胃癌中ICOS Foxp3肿瘤浸润淋巴细胞是预后标志物及与幽门螺杆菌相关的效应调节性T细胞。
Int J Cancer. 2017 Feb 1;140(3):686-695. doi: 10.1002/ijc.30475. Epub 2016 Oct 27.
9
Suppressive IL-17AFoxp3 and ex-Th17 IL-17AFoxp3 T cells are a source of tumour-associated T cells.抑制性的 IL-17A+Foxp3+ 和前 Th17 细胞 IL-17A+Foxp3+T 细胞是肿瘤相关 T 细胞的来源。
Nat Commun. 2017 Mar 14;8:14649. doi: 10.1038/ncomms14649.
10
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.具有高度免疫抑制特性的调节性T细胞在乳腺肿瘤微环境中的优先积累。
Oncotarget. 2017 May 16;8(20):33159-33171. doi: 10.18632/oncotarget.16565.

引用本文的文献

1
Therapeutic potential of targeting LAG-3 in cancer.靶向淋巴细胞活化基因3(LAG-3)在癌症治疗中的潜力。
J Immunother Cancer. 2025 Jul 8;13(7):e011652. doi: 10.1136/jitc-2025-011652.
2
Natural killer cells: the immune frontline against circulating tumor cells.自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
3
A hemoperfusion column selectively adsorbs LAP+ lymphocytes to improve anti-tumor immunity and survival of tumor-bearing rats.血液灌流柱选择性吸附LAP+淋巴细胞以提高荷瘤大鼠的抗肿瘤免疫力和生存率。

本文引用的文献

1
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.CD49b 和 LAG-3 的共表达可鉴定人和小鼠 T 调节型 1 细胞。
Nat Med. 2013 Jun;19(6):739-46. doi: 10.1038/nm.3179. Epub 2013 Apr 28.
2
Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.人类天然 FOXP3+T 调节性细胞亚群中存在 Helios+和 Helios-细胞。
J Immunol. 2013 Mar 1;190(5):2001-8. doi: 10.4049/jimmunol.1201379. Epub 2013 Jan 28.
3
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.
PLoS One. 2025 Mar 7;20(3):e0305153. doi: 10.1371/journal.pone.0305153. eCollection 2025.
4
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function.超越 FOXP3 定义人类调节性 T 细胞:需要将表型与功能相结合。
Cells. 2024 May 30;13(11):941. doi: 10.3390/cells13110941.
5
Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer.基于文献计量学的分析揭示 LAG-3 在癌症中的演进轨迹和潜在方向。
Front Immunol. 2024 Feb 8;15:1329775. doi: 10.3389/fimmu.2024.1329775. eCollection 2024.
6
Exogenous α-ketoglutarate Modulates Redox Metabolism and Functions of Human Dendritic Cells, Altering Their Capacity to Polarise T Cell Response.外源性α-酮戊二酸调节人树突状细胞的氧化还原代谢和功能,改变其极化 T 细胞反应的能力。
Int J Biol Sci. 2024 Jan 20;20(3):1064-1087. doi: 10.7150/ijbs.91109. eCollection 2024.
7
Acquisition of suppressive function by conventional T cells limits antitumor immunity upon T depletion.常规 T 细胞获得抑制功能会限制 T 细胞耗竭后抗肿瘤免疫。
Sci Immunol. 2023 Dec 15;8(90):eabo5558. doi: 10.1126/sciimmunol.abo5558.
8
Effects of immunosuppressants on T-cell dynamics: Understanding from a generic coarse-grained immune network model.免疫抑制剂对 T 细胞动力学的影响:从通用的粗粒化免疫网络模型角度理解。
J Biosci. 2022;47(4). doi: 10.1007/s12038-022-00312-4.
9
Colorectal Cancer and Purinergic Signalling: An Overview.结直肠癌与嘌呤能信号传导:综述
Cancers (Basel). 2022 Oct 6;14(19):4887. doi: 10.3390/cancers14194887.
10
Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment.结直肠癌肿瘤微环境中浸润免疫细胞上的检查点分子。
Front Med (Lausanne). 2022 Aug 22;9:955599. doi: 10.3389/fmed.2022.955599. eCollection 2022.
Neuropilin-1 在体内调节性 T 细胞亚群中区分天然和诱导性调节性 T 细胞。
J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19. doi: 10.1084/jem.20120822. Epub 2012 Sep 10.
4
LAP+CD4+ T cells are suppressors accumulated in the tumor sites and associated with the progression of colorectal cancer.LAP+CD4+ T 细胞是在肿瘤部位积累的抑制细胞,与结直肠癌的进展有关。
Clin Cancer Res. 2012 Oct 1;18(19):5224-33. doi: 10.1158/1078-0432.CCR-12-0211. Epub 2012 Aug 9.
5
Adoptive immunotherapy for cancer: harnessing the T cell response.癌症的过继免疫疗法:利用 T 细胞应答。
Nat Rev Immunol. 2012 Mar 22;12(4):269-81. doi: 10.1038/nri3191.
6
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells.卵巢癌的进展受树突状细胞表型变化的控制。
J Exp Med. 2012 Mar 12;209(3):495-506. doi: 10.1084/jem.20111413. Epub 2012 Feb 20.
7
Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.结肠腺癌中 CCR4⁺CTLA-4 FOXP3⁺CD25(hi) 调节性 T 细胞的积累与常规 T 细胞活化减少相关。
PLoS One. 2012;7(2):e30695. doi: 10.1371/journal.pone.0030695. Epub 2012 Feb 1.
8
Suppression of tumour-specific CD4⁺ T cells by regulatory T cells is associated with progression of human colorectal cancer.调节性T细胞对肿瘤特异性CD4⁺ T细胞的抑制作用与人类结直肠癌的进展相关。
Gut. 2012 Aug;61(8):1163-71. doi: 10.1136/gutjnl-2011-300970. Epub 2011 Dec 29.
9
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.免疫抑制分子 LAG-3 和 PD-1 协同调节 T 细胞功能,促进肿瘤免疫逃逸。
Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20.
10
Suppression assays with human T regulatory cells: a technical guide.抑制人 T 调节细胞的实验:技术指南
Eur J Immunol. 2012 Jan;42(1):27-34. doi: 10.1002/eji.201141651. Epub 2011 Dec 12.